Advanced Practice Provider (APP) Lecture Series – Metabolic Surgery: Progenitor of Effective Therapy For The World’s Majority of Major Diseases
Recorded October 17, 2024
Speaker: Henry Buchwald, MD PhD
Moderator: William Gourash, PhD CRNP RN CBN FASMBS-IH and Karen Flanders, NP-C CBN FASMBS-IH
Claim CME / CEU
- FREE to ASMBS Members
- $35 Non-members
*Ends October 17, 2025
Questions about claiming credits, contact education@asmbs.org
Description:
This webinar introduced the origins of metabolic surgery, and highlights metabolic surgery as the progenitor to current pharmaceutical therapeutics which target obesity and remission of chronic disease processes.
Target Audience
APP, Surgeons, RN, RD, PhD
Objectives
- Identify the history and genesis of metabolic surgery
- Describe the effects and longterm outcomes of partial ileal bypass on atherosclerotic heart disease and hyperlipidemia
- Discuss the origins of gastric bypass as recognized for remission of type 2 diabetes
- Distinguish metabolic surgery as progenitor to pharmaceutical therapeutics
Accreditation Statement
The American Society for Metabolic and Bariatric Surgery is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
The American Society for Metabolic and Bariatric Surgery designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosures
All relevant financial relationships have been mitigated.
- Henry Buchwald, MD PhD – Speaker – No Relevant Financial Relationships
- Karen Flanders, NP-C CBN FASMBS-IH
- William Gourash, PhD CRNP RN CBN FASMBS-IH